Back to 
BNP PARIBAS FINANCIAL MARKETS
BNP PARIBAS FINANCIAL MARKETS
BLRX5 quarters
Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in BIOLINE RX LIMITED
Yes. BNP Paribas Financial Markets holds 500 shares of BLRX (Bioline RX), worth $1,550, as of its Q2 2026 13F filing. It reduced the position by 1,300 shares (-72.2%) from Q1 2026. BNP Paribas Financial Markets has held BLRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$1,550
Current Shares
500
Total Value Change
-$3,624
Total Shares Change
-1,248
Quarter-by-Quarter History
Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SIMPLEX TRADING, LLC